Apoptosis induction following combined RAF-MEK-ERK pathway and MCL-1 inhibition was similarly observed in primary melanoma cell lines and in xenograft tumor models, including both drug naïve and resistant patient-derived xenografts, where in all cases the combination led to more penetrant and durable responses than ERK pathway inhibition alone. This evidence concerns the gene MCL1 and neoplasm.